Transaction details
Vida Pharma
Ethica Group with White Bridge Investments in the entry into the capital of Vida Pharma
Ethica Group, with the M&A and Debt Advisory teams, assisted White Bridge Investments in its entry into the capital of Vida Pharma, a company active in the development and production of injectable medical devices, cosmetics for professional and retail use.
WBI believes that Vida represents Italian excellence with high potential in the sector of aesthetic medicine and professional cosmetics, with a strong focus on the quality and effectiveness of the products, in line with main market trends. The deal, through the strengthening of the managerial structure, the expansion of the product portfolio, the investment in new technologies and scientific studies, as well as the further international expansion, will guarantee relevant growth opportunities while creating further value.